List of Tables
Table 1. Global CAR-T Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CD19
Table 3. Key Players of CD22
Table 4. Key Players of Other
Table 5. Global CAR-T Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global CAR-T Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CAR-T Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global CAR-T Therapy Market Share by Region (2020-2025)
Table 9. Global CAR-T Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global CAR-T Therapy Market Share by Region (2026-2031)
Table 11. CAR-T Therapy Market Trends
Table 12. CAR-T Therapy Market Drivers
Table 13. CAR-T Therapy Market Challenges
Table 14. CAR-T Therapy Market Restraints
Table 15. Global CAR-T Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global CAR-T Therapy Market Share by Players (2020-2025)
Table 17. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2024)
Table 18. Ranking of Global Top CAR-T Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by CAR-T Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of CAR-T Therapy, Headquarters and Area Served
Table 21. Global Key Players of CAR-T Therapy, Product and Application
Table 22. Global Key Players of CAR-T Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CAR-T Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global CAR-T Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global CAR-T Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global CAR-T Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global CAR-T Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global CAR-T Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global CAR-T Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global CAR-T Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific CAR-T Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific CAR-T Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific CAR-T Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG CAR-T Therapy Product
Table 50. Novartis AG Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Kite Pharma Company Details
Table 53. Kite Pharma Business Overview
Table 54. Kite Pharma CAR-T Therapy Product
Table 55. Kite Pharma Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 56. Kite Pharma Recent Development
Table 57. Pfizer Company Details
Table 58. Pfizer Business Overview
Table 59. Pfizer CAR-T Therapy Product
Table 60. Pfizer Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Juno Therapeutics Company Details
Table 63. Juno Therapeutics Business Overview
Table 64. Juno Therapeutics CAR-T Therapy Product
Table 65. Juno Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 66. Juno Therapeutics Recent Development
Table 67. Celgene Corporation Company Details
Table 68. Celgene Corporation Business Overview
Table 69. Celgene Corporation CAR-T Therapy Product
Table 70. Celgene Corporation Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 71. Celgene Corporation Recent Development
Table 72. CARsgen Therapeutics Company Details
Table 73. CARsgen Therapeutics Business Overview
Table 74. CARsgen Therapeutics CAR-T Therapy Product
Table 75. CARsgen Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 76. CARsgen Therapeutics Recent Development
Table 77. Sorrento Therapeutics Company Details
Table 78. Sorrento Therapeutics Business Overview
Table 79. Sorrento Therapeutics CAR-T Therapy Product
Table 80. Sorrento Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 81. Sorrento Therapeutics Recent Development
Table 82. Legend Biotech Company Details
Table 83. Legend Biotech Business Overview
Table 84. Legend Biotech CAR-T Therapy Product
Table 85. Legend Biotech Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 86. Legend Biotech Recent Development
Table 87. Atara Biotherapeutics Company Details
Table 88. Atara Biotherapeutics Business Overview
Table 89. Atara Biotherapeutics CAR-T Therapy Product
Table 90. Atara Biotherapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 91. Atara Biotherapeutics Recent Development
Table 92. Aurora Biopharma Company Details
Table 93. Aurora Biopharma Business Overview
Table 94. Aurora Biopharma CAR-T Therapy Product
Table 95. Aurora Biopharma Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 96. Aurora Biopharma Recent Development
Table 97. Autolus Therapeutics PLC Company Details
Table 98. Autolus Therapeutics PLC Business Overview
Table 99. Autolus Therapeutics PLC CAR-T Therapy Product
Table 100. Autolus Therapeutics PLC Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 101. Autolus Therapeutics PLC Recent Development
Table 102. Bluebird Company Details
Table 103. Bluebird Business Overview
Table 104. Bluebird CAR-T Therapy Product
Table 105. Bluebird Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 106. Bluebird Recent Development
Table 107. Carina Biotech Company Details
Table 108. Carina Biotech Business Overview
Table 109. Carina Biotech CAR-T Therapy Product
Table 110. Carina Biotech Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
Table 111. Carina Biotech Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. CAR-T Therapy Picture
Figure 2. Global CAR-T Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Therapy Market Share by Type: 2024 VS 2031
Figure 4. CD19 Features
Figure 5. CD22 Features
Figure 6. Other Features
Figure 7. Global CAR-T Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global CAR-T Therapy Market Share by Application: 2024 VS 2031
Figure 9. Acute Lymphocytic Leukemia Case Studies
Figure 10. Diffuse Large B Cell Lymphoma Case Studies
Figure 11. Follicular Lymphoma Case Studies
Figure 12. Chronic Lymphocytic Leukemia Case Studies
Figure 13. Multiple Myeloma Case Studies
Figure 14. Other Case Studies
Figure 15. CAR-T Therapy Report Years Considered
Figure 16. Global CAR-T Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global CAR-T Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global CAR-T Therapy Market Share by Region: 2024 VS 2031
Figure 19. Global CAR-T Therapy Market Share by Players in 2024
Figure 20. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by CAR-T Therapy Revenue in 2024
Figure 22. North America CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America CAR-T Therapy Market Share by Country (2020-2031)
Figure 24. United States CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe CAR-T Therapy Market Share by Country (2020-2031)
Figure 28. Germany CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific CAR-T Therapy Market Share by Region (2020-2031)
Figure 36. China CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America CAR-T Therapy Market Share by Country (2020-2031)
Figure 44. Mexico CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa CAR-T Therapy Market Share by Country (2020-2031)
Figure 48. Turkey CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Novartis AG Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 52. Kite Pharma Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 54. Juno Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 55. Celgene Corporation Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 56. CARsgen Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 57. Sorrento Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 58. Legend Biotech Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 59. Atara Biotherapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 60. Aurora Biopharma Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 61. Autolus Therapeutics PLC Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 62. Bluebird Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 63. Carina Biotech Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed